作者：
Yangyang,Wang [1]
;
Chuying,Sun [2]
;
Yutang,Cao [2]
;
Tingying,Jiao [3]
;
Kanglong,Wang [4]
;
Jiaqi,Li [5]
;
Mengjiao,Zhang [2]
;
Jie,Jiang [6]
;
Xianchun,Zhong [4]
;
Shuwu,Yu [4]
;
Hualing,Xu [2]
;
Jiawen,Wang [4]
;
Tong,Yi [7]
;
Xiaoting,Tian [4]
;
Haiyan,Zhu [7]
;
Haifeng,Zhou [8]
;
Chenggang,Huang [9]
;
Tong,Wu [10]
;
Xiaozhen,Guo [11]
;
Cen,Xie [12]
作者单位：
National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai, 201203, China; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
[1]
School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
[2]
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China; State Key Laboratory of Genetic Engineering, School of Life Sciences, Human Phenome Institute, Fudan University, Shanghai, 200032, China.
[3]
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
[4]
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China; University of Chinese Academy of Sciences, Beijing, 100049, China.
[5]
Division of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
[6]
Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, 200032, China.
[7]
National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai, 201203, China.
[8]
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. Electronic address: cghuang@simm.ac.cn.
[9]
National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai, 201203, China. Electronic address: wutong1@sinopharm.com.
[10]
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. Electronic address: guoxz@simm.ac.cn.
[11]
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China; University of Chinese Academy of Sciences, Beijing, 100049, China. Electronic address: xiecen@simm.ac.cn.
[12]
DOI
10.1016/j.jep.2024.119025
PMID
39489360
发布时间
2024-12-06
换一批
换一批
